Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.70 $16.59 Friday, 10th May 2024 NVCR stock ended at $16.47. This is 2.11% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.56% from a day low at $16.02 to a day high of $16.59.
90 days $11.70 $18.04
52 weeks $10.87 $83.60

Historical NovoCure Limited prices

Date Open High Low Close Volume
Jan 24, 2024 $14.39 $14.52 $13.91 $14.01 950 840
Jan 23, 2024 $14.89 $15.33 $13.98 $14.16 1 146 248
Jan 22, 2024 $13.95 $14.76 $13.67 $14.56 1 360 447
Jan 19, 2024 $14.62 $14.99 $13.95 $13.98 1 600 194
Jan 18, 2024 $12.94 $15.67 $12.85 $14.50 6 175 124
Jan 17, 2024 $12.35 $12.44 $11.92 $12.42 974 222
Jan 16, 2024 $13.14 $13.14 $12.49 $12.59 1 054 299
Jan 12, 2024 $13.63 $14.39 $13.26 $13.39 839 359
Jan 11, 2024 $13.97 $14.20 $13.36 $13.54 712 771
Jan 10, 2024 $14.77 $14.77 $13.24 $14.02 1 341 943
Jan 09, 2024 $15.04 $15.66 $14.70 $14.73 1 607 488
Jan 08, 2024 $13.30 $15.01 $13.30 $14.86 1 844 898
Jan 05, 2024 $13.34 $13.80 $13.02 $13.31 1 104 697
Jan 04, 2024 $13.35 $13.92 $13.22 $13.50 1 142 049
Jan 03, 2024 $14.12 $14.12 $13.31 $13.37 1 160 683
Jan 02, 2024 $14.71 $15.24 $14.37 $14.40 1 088 697
Dec 29, 2023 $15.69 $15.73 $14.68 $14.93 1 335 830
Dec 28, 2023 $15.24 $16.05 $15.04 $15.78 2 521 084
Dec 27, 2023 $13.70 $15.35 $13.59 $15.18 2 050 996
Dec 26, 2023 $13.32 $13.66 $13.24 $13.53 957 279
Dec 22, 2023 $13.43 $13.70 $13.20 $13.30 735 839
Dec 21, 2023 $13.17 $13.38 $12.99 $13.35 898 043
Dec 20, 2023 $13.50 $13.63 $12.86 $12.92 836 515
Dec 19, 2023 $13.60 $14.00 $13.43 $13.63 885 492
Dec 18, 2023 $13.56 $13.59 $13.19 $13.40 1 299 534
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT